Clinical Edge Journal Scan

Increased risk for dementia among patients with clinically active RA


 

Key clinical point: Patients with rheumatoid arthritis (RA) who had symptoms of clinically active RA and cardiovascular disease were at an increased risk for dementia.

Major finding: Apart from the universally recognized risk factors for dementia, such as older age at RA incidence, hypertension, depression, and anxiety, RA disease characteristics, such as the presence of rheumatoid nodules (adjusted hazard ratio [aHR] 1.76; 95% CI 1.05-2.95), large joint swellings (aHR 2.11; 95% CI 1.33-3.34), and any cardiovascular disease at anytime after RA incidence (aHR 2.25; 95% CI 1.38-3.66) were significantly associated with an increased risk for dementia.

Study details: This was a retrospective cohort study including 886 patients with incident RA and without prior dementia, of which 103 patients developed dementia during a median follow-up of 8.5 years.

Disclosures: This study was supported by the US National Institutes of Health, National Institute of Aging, and National Institute of Arthritis and Musculoskeletal and Skin Diseases. M Vassilaki reported receiving research funding and owning equity in various companies. MM Mielke reported receiving research grants or funding from and serving as a consultant for various sources.

Source: Kodishala C et al. Risk factors for dementia in patients with incident rheumatoid arthritis: A population-based cohort study. J Rheumatol. 2022 (Jul 15). Doi: 10.3899/jrheum.220200

Recommended Reading

Commentary: Concomitant Lung Disease, Drug Efficacy, and Potential Misdiagnosis in RA, August 2022
MDedge Rheumatology
ACR makes changes to adult, pediatric vaccinations guidance
MDedge Rheumatology
In RA, tofacitinib shows higher infection rate than TNF inhibitors
MDedge Rheumatology
Biosimilar-to-biosimilar switches deemed safe and effective, systematic review reveals
MDedge Rheumatology
FDA approves adalimumab-bwwd biosimilar (Hadlima) in high-concentration form
MDedge Rheumatology
Early methotrexate does not prevent progression to arthritis in arthralgia patients at risk for RA
MDedge Rheumatology
TNFi use during pregnancy in women with RA increases birth weight of offspring
MDedge Rheumatology
Risk for herpes zoster with first-line b/tsDMARD in seropositive RA in real world
MDedge Rheumatology
RA: Stopping bDMARD early in pregnancy increases risk for disease flare and preterm delivery
MDedge Rheumatology
Meta-analysis evaluates safety and efficacy of JAKi in RA
MDedge Rheumatology